Oura Integrates Dexcom CGM for Metabolic Health
Oura at $500M/year growing 120% YoY
Dexcom’s $75M check turned Oura’s move into metabolic health from a feature launch into a distribution and data partnership with a category leader. Instead of asking users to trust ring data alone, Oura can combine sleep, stress, activity, and heart signals from the ring with continuous glucose readings from Dexcom’s Stelo sensor, which makes the app more useful after every meal, workout, and night of sleep, and gives Dexcom a consumer friendly front end beyond diabetes care.
-
The practical workflow is simple. A user wears the ring, applies a Stelo patch, logs or photographs meals in the app, and then sees how that specific meal showed up in glucose along with recovery, stress, and sleep signals. That is much closer to a daily coaching product than a standalone sensor dashboard.
-
The partnership also helps explain why Oura chose Dexcom over building glucose hardware itself. CGM is regulated, expensive, and clinically specialized. Partnering lets Oura stay focused on the ring and subscription app, while Dexcom supplies the biosensor and gains access to Oura’s large consumer wellness audience.
-
This move also keeps Oura ahead of ring rivals pushing into metabolism. Ultrahuman already links its ring to glucose monitoring, but Oura pairs that capability with a larger subscription base, a broader health app, and a strategic investor whose product is actually embedded into the experience, not just loosely connected.
The next step is for Oura to become the consumer health hub that ties passive biometrics, food logging, blood work, and glucose into one subscription. If that happens, Dexcom becomes the glucose layer inside a much larger wellness workflow, and Oura moves further away from gadget competition and closer to an everyday preventive health platform.